Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...
Once seen as a lasting medical breakthrough, antibiotics are steadily losing their effectiveness. Around the world, ...
Study Finds on MSN
Virus-built silver nanoparticles show promise against antibiotic-resistant bacteria
Virus-built silver appears much more effective against bacteria than commercial silver. In A Nutshell Lab safety tests showed ...
With antimicrobial resistance causing over 5 million deaths annually, rapid outbreak detection is critical. A German lab ...
The Brighterside of News on MSN
Scientists capture live images of bacteria battling antibiotics
For over 80 years, physicians have used polymyxins to fight dangerous Gram-negative infections. Rob Gronkowski reveals he’s ...
On a warming planet, your food supply depends on crops that can survive heat, drought and fast spreading disease. Now ...
Antibiotics once turned deadly infections into curable ones. That trust is now cracking. Across hospitals and homes, germs ...
Get Eye infections News on Telangana Today, Eye infections latest news, Eye infections news, | Telangana Today ...
A study by LV Prasad Eye Institute highlights rising antimicrobial resistance in post-cataract infections, with aggressive ...
GSK has resubmitted its NDA to the FDA for tebipenem HBr, an oral carbapenem for complicated UTIs, backed by positive phase 3 trial results.
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Cefiderocol was effective in multiple gram-negative bacterial infections, particularly in patients with complex clinical profiles and prior antibiotic exposure, with no significant difference in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback